| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/23/2008 | EP1945225A2 Method for treating primary and secondary forms of glaucoma |
| 07/23/2008 | EP1945224A1 Reduction of side effects from aromatase inhibitors used for treating breast cancer |
| 07/23/2008 | EP1945223A2 Cefquinome compositions and methods of their use |
| 07/23/2008 | EP1945222A2 Pyrrolo[2,1-f] [1,2,4] triazin-4-ylamines igf-1r kinase inhibitors for the treatment of cancer and other hyperproliferative diseases |
| 07/23/2008 | EP1945221A1 Combination of roscovitine and a hdca inhibitor to treat prolifeative diseases |
| 07/23/2008 | EP1945220A1 Pyrazolo[1,5-a]pyrimidine compounds as cannabinoid receptor antagonists |
| 07/23/2008 | EP1945219A2 Compound |
| 07/23/2008 | EP1945218A2 Use of soluble guanylate cyclase activators for treating acute and chronic lung diseases |
| 07/23/2008 | EP1945217A2 Combinations comprising a vegf receptor inhibitor and a penetration enhancer |
| 07/23/2008 | EP1945216A1 Methods for inhibiting protein kinases |
| 07/23/2008 | EP1945215A2 Sexual desire enhancing medicaments comprising benzimidazolone derivatives |
| 07/23/2008 | EP1945214A1 Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
| 07/23/2008 | EP1945213A2 3-piperidin-4-yl-indole orl-1 receptor modulators |
| 07/23/2008 | EP1945212A1 Treatment of diabetes |
| 07/23/2008 | EP1945211A1 Use of pyrroloquinoline compounds to kill clinically latent microorganisms |
| 07/23/2008 | EP1945210A1 Use of a composition comprising an antacid, a mucolytic an a gelling agent in the treatment of cold |
| 07/23/2008 | EP1945209A2 Broad spectrum antibacterial compounds |
| 07/23/2008 | EP1945208A2 Composition and synthesis of new reagents for inhibition of hiv replication |
| 07/23/2008 | EP1945207A2 Pharmaceutical use of substituted amides |
| 07/23/2008 | EP1945206A1 Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders |
| 07/23/2008 | EP1945205A2 Methods and compositions for treating disorders associated with hyperlipidemia in a mammal |
| 07/23/2008 | EP1945204A2 V-atpase inhibitors for use in the treatment of septic shock |
| 07/23/2008 | EP1945203A2 Treatment of peripheral arterial occlusive disease |
| 07/23/2008 | EP1945202A2 Mammalian hedgehog signaling inhiabitors |
| 07/23/2008 | EP1945201A2 Calcium receptor activator |
| 07/23/2008 | EP1945200A2 Composition useful for the recovery of the original trophism and pigmentation and for stimulating the growth of the tegumentary apparatuses, use thereof and products |
| 07/23/2008 | EP1945199A1 Leucine rich composition |
| 07/23/2008 | EP1945198A2 Stable pharmaceutical formulations containing escitalopram and bupropion |
| 07/23/2008 | EP1945197A1 Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist |
| 07/23/2008 | EP1945196A2 Magnesium-containing polymers for hyperphosphatemia |
| 07/23/2008 | EP1945195A2 Novel use of a nutraceutical composition comprising resveratrol for the treatment of age-related diseases |
| 07/23/2008 | EP1945190A1 Effervescent metformin composition and tablets and granules made therefrom |
| 07/23/2008 | EP1945189A2 Coated tablets having prolonged gastric retention |
| 07/23/2008 | EP1945186A2 Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent |
| 07/23/2008 | EP1945185A2 Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency |
| 07/23/2008 | EP1945184A2 Solid composites of a calicum receptor-active compound |
| 07/23/2008 | EP1945182A2 Formulations of tipifarnib for intravenous administration |
| 07/23/2008 | EP1945032A2 Improved toleration iron supplement compositions |
| 07/23/2008 | EP1945029A2 Inhibitors of ion channels |
| 07/23/2008 | EP1945028A2 Substituted nicotinamide compounds |
| 07/23/2008 | EP1885347A4 Composition and method for treating nosebleeds |
| 07/23/2008 | EP1858496B1 Transdermal therapeutic system for the administration of analgesics |
| 07/23/2008 | EP1846384B1 Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine |
| 07/23/2008 | EP1827427B1 Aryloxyethylamine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
| 07/23/2008 | EP1807094A4 Therapeutic use of cpg oligodeoxynucleotide for skin disease |
| 07/23/2008 | EP1796725B1 Treatment or prevention of unscheluded bleeding in women on progestogen containing medication |
| 07/23/2008 | EP1794152B1 Method for manufacturing enantiomeric imidazole compounds |
| 07/23/2008 | EP1782065B1 Identification of compounds for the treatment of posterior capsule opacification |
| 07/23/2008 | EP1761525B1 Thioether derivatives, their manufacture and use as pharmaceutical agents |
| 07/23/2008 | EP1744756B1 Use of meloxicam formulations in veterinary medicine |
| 07/23/2008 | EP1735285B1 Pyrazole-amine compounds for the treatment of neurodegenerative disorders |
| 07/23/2008 | EP1732933B1 Compounds for treating dyslipidemia |
| 07/23/2008 | EP1732534B1 Use of methylene amide derivatives in cardiovascular disorders |
| 07/23/2008 | EP1729724A4 Inhalent formulation containing sulfoalkyl ether gamma-cyclodextryn and corticosteroid |
| 07/23/2008 | EP1689249B1 Dietary non-essential amino acid tyrosine regulates the body weight of animals through regulating the animal appetite or food intake |
| 07/23/2008 | EP1685108B1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 07/23/2008 | EP1675823B1 Phenethanolamine derivatives for the treatment of respiratory diseases |
| 07/23/2008 | EP1671949B1 Substituted Pyridinylamines |
| 07/23/2008 | EP1664078B1 Process for the recovery of a phytolipid composition |
| 07/23/2008 | EP1663233B1 Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis |
| 07/23/2008 | EP1635840B1 Thiophenepyrimidinones as 17-beta-hydroxysteroid dehydrogenase inhibitors |
| 07/23/2008 | EP1625119B1 Substituted-1-phthalazinamines as vr-1 antagonists |
| 07/23/2008 | EP1620085B1 Use of phenoxyacetic acid derivatives for treating hyperactive bladder |
| 07/23/2008 | EP1615909B1 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases |
| 07/23/2008 | EP1603565B1 Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients |
| 07/23/2008 | EP1601349B1 Use of the enantiomer (1s, 2r) of milnacipran for the preparation of a medicament |
| 07/23/2008 | EP1597247B1 Substituted 3-(benzoylureido)-thiophene derivatives, method for the production and use thereof |
| 07/23/2008 | EP1597242B1 Hiv inhibiting 1,2,4-triazines |
| 07/23/2008 | EP1587506B1 Administration of capsaicinoids |
| 07/23/2008 | EP1575930B1 Novel retinol derivative and cosmetic composition comprising the same |
| 07/23/2008 | EP1572194B1 Anti-cancer composition comprising dmxaa |
| 07/23/2008 | EP1569933B1 Pyrrolidine and azetidine compounds as ccr5 antagonists |
| 07/23/2008 | EP1567489B1 Pyrrolidin-2-one derivatives as inhibitors of thrombin and factor xa |
| 07/23/2008 | EP1567135B1 Powder formulation for inhalation containing tiotropium |
| 07/23/2008 | EP1565464B1 4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors |
| 07/23/2008 | EP1565195B1 Anticancer or antiviral composition |
| 07/23/2008 | EP1562572B1 Pharmaceutical Solid Dispersions of Modafinil Compounds |
| 07/23/2008 | EP1551814B1 Chirale oxazole-arylpropionic acid derivatives and their use as ppar agonists |
| 07/23/2008 | EP1549633B1 Nicotine-containing, controlled release composition and method |
| 07/23/2008 | EP1527781B1 Antipruritic agent |
| 07/23/2008 | EP1517692B1 Use of gangliosides for the prevention, inhibition and treatment of sepsis |
| 07/23/2008 | EP1513535B1 Controlled release formulation of lamotrigine |
| 07/23/2008 | EP1499289B1 Volume efficient controlled release dosage form |
| 07/23/2008 | EP1490367B1 Imidazopyridine derivatives as kinase inhibitors |
| 07/23/2008 | EP1485145B1 Multiple compartment bag assembly containing dialysis fluid |
| 07/23/2008 | EP1471901B1 Spermidine derivative for the treatment of chronic neurodegenerative diseases |
| 07/23/2008 | EP1460060B1 Method of obtaining novel lutein-based formulations |
| 07/23/2008 | EP1453743B1 Pharmaceutical product and method with an adsorbent |
| 07/23/2008 | EP1435915B1 Oral dosage forms for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient |
| 07/23/2008 | EP1420774B1 Preparation and diabetic use of gibberellins |
| 07/23/2008 | EP1412361B1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 07/23/2008 | EP1401426B1 Ptpase inhibitors and method of using same |
| 07/23/2008 | EP1382603B1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof |
| 07/23/2008 | EP1342723B1 Indole derivatives and use thereof in medicines |
| 07/23/2008 | EP1328287B1 Compositions and methods for wt1 specific immunotherapy |
| 07/23/2008 | EP1326607B1 Pharmaceutical compositions containing oxapenem-3-carboxilic acids |
| 07/23/2008 | EP1326592B1 Use of polyethylene glycol ( peg ) for the manufacture of a medicament for the treatment of constipation |
| 07/23/2008 | EP1325745B1 Preventives and remedies for complications of diabetes |
| 07/23/2008 | EP1315715B1 Quinazoline derivatives as kinase inhibitors |
| 07/23/2008 | EP1296673B1 Antimicrobial coatings |